登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Nature，3月19日，Functional exhaustion of antiviral lymphocytes in COVID-19 patients》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-20

  • Functional exhaustion of antiviral lymphocytes in COVID-19 patients

    Meijuan Zheng, Yong Gao, Gang Wang, Guobin Song, Siyu Liu, Dandan Sun, Yuanhong Xu & Zhigang Tian

    Cellular & Molecular Immunology (2020)

    In December 2019, a novel coronavirus was first reported in Wuhan, China.1 It was named by the World Health Organization as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is responsible for coronavirus disease 2019 (COVID-19). Up to 28 February 2020, 79,394 cases have been confirmed according to China’s National Health Commission. Outside China, the virus has spread rapidly to over 36 countries and territories.

  • 原文来源：https://www.nature.com/articles/s41423-020-0402-2
65浏览量
原文链接
相关报告

  • 《Nature，3月17日，Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-18
    • Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients Hong-Yi Zheng, Mi Zhang, Cui-Xian Yang, Nian Zhang, Xi-Cheng Wang, Xin-Ping Yang, Xing-Qi Dong & Yong-Tang Zheng Cellular & Molecular Immunology (2020)Cite this article The novel contagious primary atypical pneumonia epidemic, which broke out in Wuhan, China, in December 2019, is now formally called Coronavirus Disease 2019 (COVID-19), with the causative virus named as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).1,2 Recent studies have shown that in addition to dyspnea, hypoxemia, and acute respiratory distress, lymphopenia, and cytokine release syndrome are also important clinical features in patients with severe SARS-CoV-2 infection.3 This suggests that homeostasis of the immune system plays an important role in the development of COVID-19 pneumonia.
    83浏览量
    原文链接

  • 《JAMA，3月19日，Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-20
    • Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State Matt Arentz, MD1; Eric Yim, MD2; Lindy Klaff, MD2; et alSharukh Lokhandwala, MD, MSc2; Francis X. Riedo, MD2; Maria Chong, MD3; Melissa Lee, MD2 JAMA. Published online March 19, 2020. doi:10.1001/jama.2020.4326 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19), is an emerging health threat.1 Until February 2020, most cases were described in non-US health systems.2,3 One of the first deaths in the US was reported at Evergreen Hospital in Kirkland, Washington. Over the following weeks, multiple cases of COVID-19 were identified in the surrounding community and treated at Evergreen Hospital. Most were attributed to US transmission, and the majority were linked to exposures at a skilled nursing facility.
    61浏览量
    原文链接